Resmed Inc Stock Total Debt
| RMD Stock | USD 177.61 3.78 2.17% |
ResMed Inc fundamentals help investors to digest information that contributes to ResMed's financial success or failures. It also enables traders to predict the movement of ResMed Stock. The fundamental analysis module provides a way to measure ResMed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ResMed stock.
As of April 19, 2024, Total Debt To Capitalization is expected to decline to 0.16. ResMed | Total Debt |
ResMed Inc Company Total Debt Analysis
ResMed's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current ResMed Total Debt | 1.58 B |
Most of ResMed's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ResMed Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
ResMed Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for ResMed is extremely important. It helps to project a fair market value of ResMed Stock properly, considering its historical fundamentals such as Total Debt. Since ResMed's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ResMed's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ResMed's interrelated accounts and indicators.
Click cells to compare fundamentals
ResMed Total Debt Historical Pattern
Today, most investors in ResMed Stock are looking for potential investment opportunities by analyzing not only static indicators but also various ResMed's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of ResMed total debt as a starting point in their analysis.
ResMed Total Debt |
| Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
ResMed Short Long Term Debt Total
Short Long Term Debt Total |
|
Based on the latest financial disclosure, ResMed Inc has a Total Debt of 1.58 B. This is 42.57% lower than that of the Health Care Equipment & Supplies sector and 36.45% higher than that of the Health Care industry. The total debt for all United States stocks is 70.29% higher than that of the company.
ResMed Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ResMed's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ResMed could also be used in its relative valuation, which is a method of valuing ResMed by comparing valuation metrics of similar companies.ResMed is currently under evaluation in total debt category among related companies.
ResMed ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, ResMed's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to ResMed's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
ResMed Institutional Holders
Institutional Holdings refers to the ownership stake in ResMed that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of ResMed's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing ResMed's value.| Shares | Bank Of New York Mellon Corp | 2023-12-31 | 1.2 M | Legal & General Group Plc | 2023-12-31 | 1.1 M | Charles Schwab Investment Management Inc | 2023-12-31 | 863.3 K | Fidelity International Ltd | 2023-12-31 | 840 K | Jpmorgan Chase & Co | 2023-12-31 | 733.4 K | Lgt Capital Partners Ltd. | 2023-12-31 | 683.8 K | Voloridge Investment Management, Llc | 2023-09-30 | 662.4 K | D. E. Shaw & Co Lp | 2023-09-30 | 657.3 K | Amundi | 2023-12-31 | 615 K | Vanguard Group Inc | 2023-12-31 | 17.7 M | Blackrock Inc | 2023-12-31 | 12.2 M |
ResMed Fundamentals
| Return On Equity | 0.22 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.20 % | ||||
| Operating Margin | 0.29 % | ||||
| Current Valuation | 28.36 B | ||||
| Shares Outstanding | 147.09 M | ||||
| Shares Owned By Insiders | 0.81 % | ||||
| Shares Owned By Institutions | 57.18 % | ||||
| Number Of Shares Shorted | 7.89 M | ||||
| Price To Earning | 73.48 X | ||||
| Price To Book | 6.10 X | ||||
| Price To Sales | 6.07 X | ||||
| Revenue | 4.22 B | ||||
| Gross Profit | 2.39 B | ||||
| EBITDA | 1.34 B | ||||
| Net Income | 897.56 M | ||||
| Cash And Equivalents | 273.71 M | ||||
| Cash Per Share | 1.87 X | ||||
| Total Debt | 1.58 B | ||||
| Debt To Equity | 0.27 % | ||||
| Current Ratio | 2.80 X | ||||
| Book Value Per Share | 30.47 X | ||||
| Cash Flow From Operations | 693.3 M | ||||
| Short Ratio | 6.91 X | ||||
| Earnings Per Share | 6.04 X | ||||
| Price To Earnings To Growth | 1.75 X | ||||
| Target Price | 202.68 | ||||
| Beta | 0.67 | ||||
| Market Capitalization | 27.19 B | ||||
| Total Asset | 6.75 B | ||||
| Retained Earnings | 4.25 B | ||||
| Working Capital | 1.61 B | ||||
| Current Asset | 1.42 B | ||||
| Current Liabilities | 637.99 M | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 1.02 % | ||||
| Net Asset | 6.75 B | ||||
| Last Dividend Paid | 1.84 |
About ResMed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ResMed Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ResMed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ResMed Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:Check out ResMed Piotroski F Score and ResMed Altman Z Score analysis. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for ResMed Stock analysis
When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Is ResMed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.07) | Dividend Share 1.84 | Earnings Share 6.04 | Revenue Per Share 30.633 | Quarterly Revenue Growth 0.125 |
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.